Immunotherapy-related cystitis induced by nivolumab: A case report and review of the literature

被引:0
作者
Yuan, Yingying [1 ,2 ]
Lou, Lianqing [3 ]
Zhu, Siheng [1 ,2 ]
Yan, Dong [1 ,2 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 1,Collaborat Innovat Ctr Diag & Tr, Natl Clin Res Ctr Infect Dis,China Singapore Belt, Natl Med Ctr Infect Dis,State Key Lab Diag & Treat, Hangzhou, Peoples R China
[2] Yuhang Inst Collaborat Innovat & Translat Res Life, Hangzhou, Peoples R China
[3] Yiwu Cent Hosp, Dept Crit Care Med, Yiwu, Zhejiang, Peoples R China
关键词
Immune checkpoint inhibitors (ICIs); Nivolumab; Immune-related cystitis; Gastric cancer;
D O I
10.1016/j.eucr.2025.103132
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Immune checkpoint inhibitors (ICIs) like nivolumab have revolutionized cancer treatment but can cause immune-related adverse events (irAEs), including rare cystitis. This case report describes a gastric cancer patient who developed urinary symptoms, such as hematuria and frequent urination, after nivolumab treatment. Despite initial antibiotics, symptoms worsened, leading to a diagnosis of immune-related cystitis. Intravenous methylprednisolone provided rapid relief and restored renal function. Early recognition and corticosteroid treatment are crucial for managing ICI-induced cystitis and preventing unnecessary antibiotics.
引用
收藏
页数:5
相关论文
共 16 条
[1]   Expression of programmed death ligand-1 on bladder tissues is detected in a clinically and histologically well-defined interstitial cystitis cohort [J].
Chen, Yuke ;
Yu, Wei ;
Yang, Yang ;
Xiao, Yunxiang ;
Cui, Yun ;
Duan, Jihong ;
He, Qun ;
Jin, Jie ;
Wu, Shiliang .
NEUROUROLOGY AND URODYNAMICS, 2018, 37 (04) :1396-1404
[2]   Adverse Events Associated with Immune Checkpoint Inhibitors: Overview of Systematic Reviews [J].
Kanji, Salmaan ;
Morin, Sydney ;
Agtarap, Kyla ;
Purkayastha, Debanjali ;
Thabet, Pierre ;
Bosse, Dominick ;
Wang, Xiang ;
Lunny, Carole ;
Hutton, Brian .
DRUGS, 2022, 82 (07) :793-809
[3]   Immune Checkpoint Inhibitors: Basics and Challenges [J].
Li, Bin ;
Chan, Ho Lam ;
Chen, Pingping .
CURRENT MEDICINAL CHEMISTRY, 2019, 26 (17) :3009-3025
[4]   Immune-related ureteritis and cystitis induced by immune checkpoint inhibitors: Case report and literature review [J].
Li, Jun ;
Yu, Ya-Fen ;
Qi, Xiao-Wei ;
Du, Yuan ;
Li, Chun-Qing .
FRONTIERS IN IMMUNOLOGY, 2023, 13
[5]   Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance [J].
Martins, Filipe ;
Sofiya, Latifyan ;
Sykiotis, Gerasimos P. ;
Lamine, Faiza ;
Maillard, Michel ;
Fraga, Montserrat ;
Shabafrouz, Keyvan ;
Ribi, Camillo ;
Cairoli, Anne ;
Guex-Crosier, Yan ;
Kuntzer, Thierry ;
Michielin, Olivier ;
Peters, Solange ;
Coukos, Georges ;
Spertini, Francois ;
Thompson, John A. ;
Obeid, Michel .
NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (09) :563-580
[6]   Strategies for improving the management of immune-related adverse events [J].
Naing, Aung ;
Hajjar, Joud ;
Gulley, James L. ;
Atkins, Michael B. ;
Ciliberto, Gennaro ;
Meric-Bernstam, Funda ;
Hwu, Patrick .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
[7]   Non-bacterial Cystitis With Increased Expression of Programmed Cell Death Ligand 1 in the Urothelium: An Unusual Immune-Related Adverse Event After Atezolizumab Administration for Metastatic Breast Cancer [J].
Obayashi, Aiko ;
Hamada-Nishimoto, Mai ;
Fujimoto, Yuri ;
Yoshimoto, Yukiko ;
Takahara, Sachiko .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (05)
[8]   A case of cystitis after administration of nivolumab [J].
Keisuke Ozaki ;
Hisaya Takahashi ;
Yoshihide Murakami ;
Hiroshi Kiyoku ;
Hiroomi Kanayama .
International Cancer Conference Journal, 2017, 6 (4) :164-166
[9]   Aseptic cystitis induced by nivolumab and ipilimumab combination for metastatic melanoma [J].
Schneider, Sophie ;
Alezra, Eric ;
Yacoub, Mokrane ;
Ducharme, Oceane ;
Gerard, Emilie ;
Dutriaux, Caroline ;
Prey, Sorilla .
MELANOMA RESEARCH, 2021, 31 (05) :487-489
[10]   Two cases of nonbacterial cystitis associated with nivolumab, the anti-programmed-death-receptor-1 inhibitor [J].
Shimatani, Kimihiro ;
Yoshimoto, Tetsuro ;
Doi, Yutaka ;
Sonoda, Takashi ;
Yamamoto, Shingo ;
Kanematsu, Akihiro .
UROLOGY CASE REPORTS, 2018, 17 :97-99